Author

Christina Sexton

Institution: Cincinnati Children's Hospital Medical Center

Observed institution: Cincinnati Children's Hospital Medical Center

ORCID: 0009-0008-8423-4619

Observed ORCID: 0009-0008-8423-4619

OpenAlex ID: A5004664566

AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model

2013 · Mark Wunderlich, Benjamin Mizukawa, et al. · Blood · 123

Improved multilineage human hematopoietic reconstitution and function in NSGS mice

2018 · Mark Wunderlich, Fu-Sheng Chou, et al. · PLoS ONE · 105

A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti–IL-6R treatment

2016 · Mark Wunderlich, Courtney Stockman, et al. · JCI Insight · 52

Improved chemotherapy modeling with RAG-based immune deficient mice

2019 · Mark Wunderlich, Nicole Manning, et al. · PLoS ONE · 29

PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of Relapsed Pediatric B-Cell Acute Lymphoblastic Leukemia

2021 · Mark Wunderlich, Nicole Manning, et al. · Frontiers in Oncology · 28

Spermidine metabolism regulates leukemia stem and progenitor cell function through KAT7 expression in patient-derived mouse models

2024 · Vincent Rondeau, Jacob M. Berman, et al. · Science Translational Medicine · 22

PDX models of relapsed pediatric AML preserve global gene expression patterns and reveal therapeutic targets

2022 · Mark Wunderlich, Jing Chen, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 7

Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation

2025 · Tianyi Ling, Cristiana O’Brien, et al. · Blood · 4

NSGS Mice Develop a Progressive, Myeloid Cell Dependent Aplastic Anemia and Bone Marrow Failure Upon Engraftment With Human Umbilical Cord Blood CD34+ Cells

2013 · Mark Wunderlich, Christina Sexton, et al. · Blood · 4

Global Gene Expression and Mutation Signatures Are Preserved in PDX Models of Pediatric AML and Aid Discovery of Targeted Therapy for Cases with CBFA2T3/GLIS2 Rearrangement

2019 · Mark Wunderlich, Jing Chen, et al. · Blood · 1

PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of B-Cell Acute Lymphoblastic Leukemia

2017 · Mark Wunderlich, Nicole Manning, et al. · Blood · 1

A Xenograft Model of Lymphocyte-Independent, Effector-Driven Macrophage Activation SyndRome Amenable to Anti-CD33 and Anti-IL-6R Treatment

2016 · Mark Wunderlich, Courtney Stockman, et al. · Blood · 1

Targeting polyamine metabolism and eIF5A hypusination in pediatric acute myeloid leukemia

2026 · Courtney Jones, Yun Chueh, et al. · Research Square

Abstract IA04: Identifying and targeting tumorigenic signals in the developing liver

2026 · Peng V. Wu, Eric O'Brien, et al. · Cancer Research

Abstract 5412: Xenograft based detection of rare leukemic clones in minimal residual disease negative diagnostic specimens from pediatric patients

2020 · Mark Wunderlich, Nicole Manning, et al. · Cancer Research

Works count: 15

Citation count: 377

H-index: 7

I10-index: 6